» Articles » PMID: 35141116

Simple Cardiovascular Risk Stratification by Replacing Total Serum Cholesterol with Anthropometric Measures: The MORGAM Prospective Cohort Project

Abstract

To assess whether anthropometric measures (body mass index [BMI], waist-hip ratio [WHR], and estimated fat mass [EFM]) are independently associated with major adverse cardiovascular events (MACE), and to assess their added prognostic value compared with serum total-cholesterol. The study population comprised 109,509 individuals (53% men) from the MORGAM-Project, aged 19-97 years, without established cardiovascular disease, and not on antihypertensive treatment. While BMI was reported in all, WHR and EFM were reported in ∼52,000 participants. Prognostic importance of anthropometric measurements and total-cholesterol was evaluated using adjusted Cox proportional-hazards regression, logistic regression, area under the receiver-operating-characteristic curve (AUC), and net reclassification improvement (NRI). The primary endpoint was MACE, a composite of stroke, myocardial infarction, or death from coronary heart disease. Age interacted significantly with anthropometric measures and total-cholesterol on MACE (P ≤ 0.003), and therefore age-stratified analyses (<50 versus ≥ 50 years) were performed. BMI, WHR, EFM, and total-cholesterol were independently associated with MACE (P ≤ 0.003) and resulted in significantly positive NRI when added to age, sex, smoking status, and systolic blood pressure. Only total-cholesterol increased discrimination ability (AUC difference; P < 0.001). In subjects < 50 years, the prediction model with total-cholesterol was superior to the model including BMI, but not superior to models containing WHR or EFM, while in those ≥ 50 years, the model with total-cholesterol was superior to all models containing anthropometric variables, whether assessed individually or combined. We found a potential role for replacing total-cholesterol with anthropometric measures for MACE-prediction among individuals < 50 years when laboratory measurements are unavailable, but not among those ≥ 50 years.

Citing Articles

First manifestation of cardiovascular disease according to age and sex in a Mediterranean country.

Ortega E, Genua I, Mata-Cases M, Roque M, Vlacho B, Real Gatius J Front Cardiovasc Med. 2024; 11:1403363.

PMID: 39355347 PMC: 11443696. DOI: 10.3389/fcvm.2024.1403363.


A Nutrigenetic Strategy for Reducing Blood Lipids and Low-Grade Inflammation in Adults with Obesity and Overweight.

Perez-Beltran Y, Gonzalez-Becerra K, Rivera-Iniguez I, Martinez-Lopez E, Ramos-Lopez O, Alcaraz-Mejia M Nutrients. 2023; 15(20).

PMID: 37892400 PMC: 10609523. DOI: 10.3390/nu15204324.


Anti-obesity effect of the bacterial product nisin in an NIH Swiss mouse model.

Al-Emarah M, Kazerani H, Taghizad F, Dehghani H, Elahi M Lipids Health Dis. 2023; 22(1):23.

PMID: 36765351 PMC: 9912503. DOI: 10.1186/s12944-023-01788-1.


A Non-Exercise Model for Predicting Cardiovascular Risks among Apparently Healthy Male Office Workers-Cross-Sectional Analysis: A Pilot Study.

Zadarko E, Zadarko-Domaradzka M, Barabasz Z, Sobolewski M Int J Environ Res Public Health. 2022; 19(5).

PMID: 35270329 PMC: 8909649. DOI: 10.3390/ijerph19052643.

References
1.
Piepoli M, Hoes A, Agewall S, Albus C, Brotons C, Catapano A . 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by.... Atherosclerosis. 2016; 252:207-274. DOI: 10.1016/j.atherosclerosis.2016.05.037. View

2.
Richardson T, Sanderson E, Elsworth B, Tilling K, Davey Smith G . Use of genetic variation to separate the effects of early and later life adiposity on disease risk: mendelian randomisation study. BMJ. 2020; 369:m1203. PMC: 7201936. DOI: 10.1136/bmj.m1203. View

3.
Clark K . Obesity and the risk of heart failure. J Insur Med. 2003; 35(1):59-60. View

4.
Dhana K, Ikram M, Hofman A, Franco O, Kavousi M . Anthropometric measures in cardiovascular disease prediction: comparison of laboratory-based versus non-laboratory-based model. Heart. 2014; 101(5):377-83. DOI: 10.1136/heartjnl-2014-306704. View

5.
Cox B, Whichelow M, Prevost A . The development of cardiovascular disease in relation to anthropometric indices and hypertension in British adults. Int J Obes Relat Metab Disord. 1998; 22(10):966-73. DOI: 10.1038/sj.ijo.0800705. View